===== DISCHARGE NOTE =====
note_id=16053405-DS-24 | hadm_id=20031861

 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
simvastatin
 
Attending: ___
 
Chief Complaint:
fevers
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
 ___ y/o M w/ hx HTN, neuropathy, s/p CVA with resultant
hemiplegia and pseudobulbar and bulbar findings also with
dysarthria and dysphagia, bilateral vocal fold atrophy, a right
vocal fold paresis, secondary muscle tension dysphonia,
wheelchair bound p/w fever.

Patient initially presented to urgent care today for his fever 
of
102.9Â°F at home. He took Tylenol at 3 ___.  Was febrile at ___ to
100.6F up to ___.  

Patient states sx ongoing x1 day PTA, c/o fever, denies CP, SOB,
nausea, vomiting, HA, diarrhea, dysuria, frequency.

Found to have a UTI at urgent care. Unable to obtain IV access 
at
___.  

Denies any flank pain, hematuria, chest pain or shortness of
breath. Last received Tylenol at 9 ___.

Prior cultures were checked but he has not had any prior 
positive
urine cultures.

 
Past Medical History:
*S/P STROKE                                                     
DYSARTHRIA                                                      
DYSPHAGIA                                                       
HEMIPLEGIA                                                      
HYPERTENSION                                                    
SNORING                                                         
NEUROPATHY                                                      
PUPULAR LESION                                                  
___                                                   
___ ___ ___                                           
H/O NEPHROLITHIASIS                                             
H/O DIABETES TYPE II                                            
H/O HYPERTRIGLYCERIDEMIA                                        
H/O OBESITY                                                     
H/O REHAB   
 
Social History:
___
Family History:
Mother   ___     LUNG CANCER  in ___, smoker; TRANSIENT 
ISCHEMIC  ATTACK    
 
Physical Exam:
Admission exam
VITALS: Afebrile and vital signs stable (see eFlowsheet)
GENERAL: Alert and in no apparent distress
EYES: Anicteric, pupils equally round
ENT: Ears and nose without visible erythema, masses, or trauma. 
Oropharynx without visible lesion, erythema or exudate
CV: Heart regular, no murmur, no S3, no S4.  No JVD.
RESP: Lungs clear to auscultation with good air movement
bilaterally.  Breathing is non-labored
GI: Abdomen soft, non-distended, non-tender to palpation.  Bowel
sounds present.  No HSM
GU: No suprapubic fullness or tenderness to palpation
MSK: left arm and lower extremity atrophy, able to lift left arm
to gravity but not under pressure, full strength in RLE/RUE, 
able
to wiggle toes on both feet, note contracture of ___ toe of
left foot in flexion, slurred speech with sounds of upper 
airways
secretion difficulties, cranial nerves intact but left shoulder
raise is weaker on left that right, note a gaze deficit on right
lateral gaze, decreased smile on left side
SKIN: No rashes or ulcerations noted
NEURO: Alert, oriented, speech fluent, moves all limbs, see MSK
above for more detail
PSYCH: pleasant, appropriate affect

Discharge exam
***
 
Pertinent Results:
Admission labs
___ 07:40PM BLOOD WBC-11.9*# RBC-4.38* Hgb-13.1* Hct-40.5 
MCV-93 MCH-29.9 MCHC-32.3 RDW-13.2 RDWSD-45.0 Plt ___
___ 07:40PM BLOOD Glucose-153* UreaN-16 Creat-0.9 Na-140 
K-3.2* Cl-104 HCO3-26 AnGap-10

 
Brief Hospital Course:
SUMMARY/ASSESSMENT:  ___ y/o M w/ hx HTN, HLD, neuropathy, s/p 
CVA with resultant hemiplegia and pseudobulbar and bulbar 
findings also with dysarthria and dysphagia, bilateral vocal 
fold atrophy, a right vocal fold paresis, secondary muscle 
tension dysphonia, wheelchair bound p/w fever.

ACUTE/ACTIVE PROBLEMS:
#Sepsis ___ Klebsiella UTI (mostly ___, resist to 
ampicillin-sulbactam and intermed to nitrofurantoin) - Pt 
presented with fever and leukocytosis with positive UA. Sepsis 
resolved within 24h of initiation of IV antibiotics with 
resolution of leukocytosis but pt continued to have intermittent 
breakthrough fevers. Pt was without breakthrough fevers for >24h 
prior to discharge, temp curve improved. Renal US was *neg* for 
hydro-uretero-nephrosis or any other e/o obstructive calculus. 
S/p IVF repletion.

#Chronic anticoagulation, supratherapeutic on admission - INR 
3.2 on admission, subsequently therapeutic per daily labs 
throughout the rest of hospitalization, goal INR ___, received 3 
mg daily throughout.

#Thrombocytopenia - patient plt count fluctuates, sometimes low, 
more often WNL, may be related to sepsis, recommend monitoring 
at this time. 138K on ___, trended down to 98K on ___, back up 
to 143K by ___.

#Hypokalemia of 3.2, repleted in ED, subsequently WNL.

CHRONIC/STABLE PROBLEMS:
#Chronic anemia - baseline Hgb 12.6, now 12.5, no overt source 
of bleeding, likely related to chronic illness, monitor
#HTN - BP stable, continue antiHTN meds
#HLD - continue statin
#Does *not have T2DM - Per record, dx has been removed, pt not 
being monitored for it. Last a1c 5.5 on ___.
#neuropathy - not currently on medical control, monitor

# Hx CVA with resultant hemiplegia and pseudobulbar and bulbar 
findings also with dysarthria and dysphagia, bilateral vocal 
fold atrophy, a right vocal fold paresis, secondary muscle 
tension dysphonia, wheelchair bound. Pt maintains outpatient 
follow up ___ times per month for voice/swallow exercises.

#Oropharyngeal dysphagia - heart healthy diet w/ consistency 
ground, Honey prethickened liquids meds crushed in puree

#upper airway secretions - continue Glycopyrrolate home med PRN
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atenolol 25 mg PO QHS 
2. ClonazePAM 0.5 mg PO QHS 
3. dextromethorphan-quinidine ___ mg oral BID 
4. Doxazosin 4 mg PO HS 
5. Glycopyrrolate 1 mg PO TID:PRN secretions 
6. Lisinopril 40 mg PO DAILY 
7. Atorvastatin 40 mg PO QPM 
8. Ketoconazole Shampoo 1 Appl TP ASDIR 
9. Warfarin 3 mg PO DAILY16 
10. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
11. nystatin 100,000 unit/gram topical BID 
12. Docusate Sodium 100 mg PO BID:PRN constipation 

 
Discharge Medications:
1.  Ciprofloxacin HCl 500 mg PO Q12H Duration: 11 Doses 
RX *ciprofloxacin HCl [Cipro] 500 mg 1 tablet(s) by mouth twice 
a day Disp #*11 Tablet Refills:*0 
2.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
3.  Atenolol 25 mg PO QHS  
4.  Atorvastatin 40 mg PO QPM  
5.  ClonazePAM 0.5 mg PO QHS  
6.  dextromethorphan-quinidine ___ mg oral BID  
7.  Docusate Sodium 100 mg PO BID:PRN constipation  
8.  Doxazosin 4 mg PO HS  
9.  Glycopyrrolate 1 mg PO TID:PRN secretions  
10.  Ketoconazole Shampoo 1 Appl TP ASDIR  
11.  Lisinopril 40 mg PO DAILY  
12.  nystatin 100,000 unit/gram topical BID  
13.  Warfarin 3 mg PO DAILY16  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Pyelonephritis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Mr. ___

You were admitted for fevers and found to have a urinary tract 
infection which also caused an initial period of stress on the 
body called sepsis. The sepsis resolved promptly with initiation 
of IV antibiotics and the UTI has continued to respond 
throughout the hospitalization.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=16053405-DS-19 | hadm_id=20112244

 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
simvastatin
 
Attending: ___.
 
Chief Complaint:
Double vision, vertigo, unbalanced
 
Major Surgical or Invasive Procedure:
Tracheostomy placement
PEG tube placement

 
History of Present Illness:
___ is a ___ M with a h/o DM, HTN, HLD, BPPV who 
presents with sudden onset nausea, slurred speech, nystagmus, 
clumsiness at noon on ___. The patient was at home ___ his 
normal state of health at symptom onset. He called his wife when 
the symptoms started and laid down to rest on the couch. When 
his wife arrived home 1.5 hours later she noted slurred speech 
and "wiggling eyes." At that time the patient wished to wait it 
out to see if the symptoms would resolve on their own. They did 
not and he presented to ___ around 5pm. At ___ he 
had a CT of the head which was concerning for right transverse 
sinus thrombosis. He then had an MRI/MRV of the brain, which 
showed bilateral cerebellar infarcts and a right thalamic 
infact. He was transferred to ___. His symptoms have been 
constant since onset and has not had any significant worsening. 
They do not seem to be blood pressure or position dependent.

On neuro ROS, the pt denies headache, loss of vision, blurred 
vision, diplopia, dysphagia, lightheadedness, tinnitus or 
hearing difficulty. Denies difficulties producing or 
comprehending speech. Denies focal weakness, numbness, 
parasthesiae. No bowel or bladder incontinence or retention. 
Denies difficulty with gait.

On general review of systems, the pt denies recent fever or 
chills. No night sweats or recent weight loss or gain. Denies 
cough, shortness of breath. Denies chest pain or tightness, 
palpitations. Denies nausea, vomiting, diarrhea, constipation or 
abdominal pain. No recent change ___ bowel or bladder habits. No 
dysuria. Denies arthralgias or myalgias. Denies rash.

 
Past Medical History:
BPPV
HTN
HLD
 
Social History:
___
Family History:
___: No h/o strokes, clotting disorders. Mother died of lung 
cancer (smoker)
 
Physical Exam:
ADMISSION EXAM
97.7 81 134/81 20 98% 2L 
GEN: Awake, cooperative, NAD.
HEENT: NC/AT, anicteric, MMM, no lesions noted ___ oropharynx
RESP: Non-labored
CV: RRR
ABD: soft, NT/ND
EXT: No edema, no cyanosis
SKIN: no rashes or lesions noted.

NEURO EXAM:
MS:
Alert, oriented x 3.
Able to relate history without difficulty.
Attentive
Language is fluent with intact repetition and comprehension.
Normal prosody.
There were no paraphasic errors.
Dysarthric.
Able to follow both midline and appendicular commands.
No evidence of apraxia or neglect.

CN:
II:
PERRLA 3 to 2mm and brisk.
III, IV, VI: EOMI, no nystagmus. Normal saccades.
V: Sensation intact to LT.
VII: Facial musculature symmetric.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate rise symmetric.
XI: Trapezius and SCM ___ bilaterally.
XII: Tongue protrudes midline.

Motor:
Normal bulk, tone throughout. Mild drift of RUE with 
outstretched
arms, no pronation.
No adventitious movements. No asterixis.
  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___
L   ___   ___  ___    ___      5   5
R   ___   ___  ___    ___      5   5

Sensory: No deficits to light touch, proprioception throughout.
No extinction to DSS.

Reflexes:
  ___ Tri ___ Pat Ach
L  ___     2   1
R  ___     2   1
Toes upgoing bilaterally

Coordination:
Ataxia on FNF R>L. Mild ataxia bilaterally on HKS.

=========================================================
DISCHARGE EXAMINATION:
VItals: Tm 99.8 Tc 98.4 BP 133-152/73-92 HR ___ RR ___ POX 
95% on 35% FiO2
GEN: Awake, cooperative
HEENT: Trach with trach mask ___ place
CV: RRR s1 s2
PULM: bibasilar dry crackles on anterior auscultation.
ABD: soft, NT/ND, + PEG ___ place, c/d/i, non erythematous
EXT: No edema, no cyanosis

NEURO EXAM:
MS:  Alert, regards to examiner.  Nods yes/no appropriately. 
Does not vocalize.  Able to follow commands to squeeze right 
hand, show two fingers, lift right arm & leg. He is also playing 
word finds with his wife and communicating via yes no options.

CRANIAL NERVES:
II: 3 mm reactive sluggish pupils bilaterally
III, IV, VI: skew deviation. Right eye midline on primary gaze 
with minimal movements (minimal downgaze is present).  Left eye 
is exotropic on primary gaze with restricted movements (he 
adducts and only partially abducts).  
V: Sensation intact to light touch.
VII: Left lower facial droop.
VIII: Hearing intact
IX, X: + cough, gag
XI: Trapezius and SCM ___ bilaterally.
XII: Tongue midline.

MOTOR: Normal bulk.  Tone is decreased ___ left upper and lower 
extremities, normal on the right.  RUE/RLE moves to command ___ 
throughout.  LLE with trace toe wiggle and quad activation with 
concerted effort.  LUE with trace shoulder movement, otherwise 
plegic on this left arm.  Right side with full strength. 

SENSORY: Intact to light touch on both arms and legs

Reflexes: Right arm brisker than the left. Crossed adduction on 
tapping left patellar.  Toes upgoing bilaterally
 
Pertinent Results:
======================================
ADMISSION LABS:
___ 07:58AM   WBC-13.9* RBC-4.45* HGB-13.8* HCT-41.2 MCV-93 
MCH-31.1 MCHC-33.5 RDW-12.3
___ 07:58AM   PLT COUNT-262
___ 09:10PM   GLUCOSE-142* UREA N-9 CREAT-0.8 SODIUM-141 
POTASSIUM-3.1* CHLORIDE-101 TOTAL CO2-28 ANION GAP-15
___ 09:10PM   CALCIUM-9.3 PHOSPHATE-1.5* MAGNESIUM-1.9
___ 09:10PM   PTT-49.9*
___ 07:58AM   CK(CPK)-256
___ 07:58AM   CK-MB-3 cTropnT-<0.01

URINE: 
___ 02:37PM URINE Color-Yellow Appear-Clear Sp ___ 
Blood-NEG Nitrite-NEG Protein-NEG Glucose-150 Ketone-TR 
Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG

======================================

DISCHARGE LABS:
___ 03:05AM BLOOD WBC-15.1* RBC-4.05* Hgb-12.5* Hct-38.0* 
MCV-94 MCH-31.0 MCHC-33.0 RDW-12.8 Plt ___
___ 09:24AM BLOOD ___ PTT-61.0* ___
___ 03:05AM BLOOD Glucose-182* UreaN-17 Creat-0.9 Na-138 
K-4.0 Cl-100 HCO3-31 AnGap-11
___ 03:05AM BLOOD Calcium-10.0 Phos-4.4 Mg-2.1
___ 09:20AM BLOOD ALT-34 AST-29 AlkPhos-55 TotBili-0.4

URINE: 
___ 11:17AM URINE Color-Straw Appear-Clear Sp ___ 
Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG 
Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG

======================================

MICROBIOLOGY: 
___ URINE URINE CULTURE- no growth.

___ 1:15 am SPUTUM      Source: Endotracheal. 
   GRAM STAIN (Final ___: 
      ___ PMNs and <10 epithelial cells/100X field. 
      3+  ___ per 1000X FIELD):   GRAM POSITIVE COCCI. 
                                    ___ PAIRS AND CLUSTERS. 
      2+   ___ per 1000X FIELD):   GRAM NEGATIVE ROD(S). 
      1+    (<1 per 1000X FIELD):   GRAM POSITIVE ROD(S). 
      SMEAR REVIEWED; RESULTS CONFIRMED. 
   RESPIRATORY CULTURE (Final ___: 
      SPARSE GROWTH Commensal Respiratory Flora. 
      STAPH AUREUS COAG +.    MODERATE GROWTH. 
         ____________________________________                    
         STAPH AUREUS COAG +
                             |   
CLINDAMYCIN-----------<=0.25 S
ERYTHROMYCIN----------<=0.25 S
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN----------  0.25 S
OXACILLIN-------------<=0.25 S
TETRACYCLINE----------   <=1 S
TRIMETHOPRIM/SULFA---- <=0.5 S

.
.
.
.
.
.
.
.
................................................................

___ 2:18 pm SPUTUM      Source: Endotracheal. 
   GRAM STAIN (Final ___: 
      ___ PMNs and <10 epithelial cells/100X field. 
      1+    (<1 per 1000X FIELD):   MULTIPLE ORGANISMS 
CONSISTENTWITH     
                                    OROPHARYNGEAL FLORA. 
   RESPIRATORY CULTURE (Final ___: 
      SPARSE GROWTH Commensal Respiratory Flora. 

___ Blood Culture, Routine-PENDING INPATIENT 
___ Blood Culture, Routine-PENDING INPATIENT 
___ URINE CULTURE (Final ___:    NO GROWTH.

===========================================================
IMAGING: 

CTA Head and Neck ___:
1. Subtle small scattered small hypodensities within the 
cerebellum and 
brainstem, better evaluated on recent prior MRI of the head, 
consistent with acute infarctions ___ the posterior circulation. 
2. Complete occlusion of the mid to distal basilar artery with 
absence of 
right superior cerebellar and anterior inferior cerebellar 
arteries. There is severe atherosclerotic disease of the left 
vertebral artery and basilar artery with irregularity of the V4 
segment of the left vertebral artery. Findings are consistent 
with complete occlusion secondary to severe atherosclerotic 
disease. 
3. Diffuse irregularity ___ the intracranial arteries, 
particularly at the 
right M2 segment and bilateral carotid siphons, without evidence 
of high-grade narrowing. 
4. Diffuse moderate atherosclerosis of the neck vasculature with 
narrowing of the bilateral internal carotid artery origins, 22% 
on the right and 10% on the left, but NASCET criteria. 

TTE ___
The left atrial volume index is mildly increased. No atrial 
septal defect or patent foramen ovale is seen by 2D, color 
Doppler or saline contrast with maneuvers. There is mild 
symmetric left ventricular hypertrophy with normal cavity size 
and global systolic function (LVEF>60%). Due to suboptimal 
technical quality, a focal wall motion abnormality cannot be 
fully excluded. Right ventricular chamber size and free wall 
motion are normal. The aortic valve leaflets (3) appear 
structurally normal with good leaflet excursion and no aortic 
stenosis. No aortic regurgitation is seen. The mitral valve 
appears structurally normal with trivial mitral regurgitation. 
The estimated pulmonary artery systolic pressure is normal. 
There is no pericardial effusion. 
IMPRESSION: Suboptimal image quality. Normal global 
biventricular systolic function. No cardiac source of embolism 
seen. No pathologic valvular abnormalities..

ECHO ___
Sinus rhythm. Left atrial abnormality. A-V conduction delay. 
Compared to the previous tracing of ___ no diagnostic 
interim change. 
  
NCHCT ___
Redemonstrated is hyperdensity of the basilar artery, 
particularly 
at the terminus with extensive calcification, consistent with 
patient's known  thrombus within the basilar artery.  There 
appears to be interval progression of hypodensity along the 
midbrain and cerebellum, concerning for worsening ischemia ___ 
these regions.  No acute hemorrhage is identified.  The basilar 
cisterns are patent.  There is no evidence of herniation. No 
acute fracture is identified.  Secretions are seen ___ the 
oropharynx. There is mucosal thickening of the maxillary sinuses 
bilaterally.  The frontal sinuses and sphenoid sinuses 
demonstrate mild air-fluid levels and mucosal thickening. The 
mastoid air cells and middle ear cavities are clear. IMPRESSION: 
Interval progression of hypodensity ___ the midbrain and 
cerebellum is concerning for worsening ischemia.  No evidence of 
herniation. 

CXR ___: Compared to the prior radiographs the lung volumes are 
stable. There is no focal opacity, pleural effusion or 
pneumothorax. The cardiomediastinal contours are stable. 

CXR ___: 
___ comparison with the earlier study of this date, of the 
endotracheal tube has been removed and replaced with a 
tracheostomy tube that appears to be well as positioned without 
evidence of complication. The patient is somewhat oblique when 
compared to the previous study. This may account for the 
apparent increased opacification at the right base. There does 
appear to be some relative elevation of the right 
hemidiaphragmatic contour.  A ___ the appropriate clinical 
setting, the possibility of volume loss ___ the right lower lung 
could be considered. 

CXR ___: 
Tracheostomy tube appears ___ unchanged position. As does 
right-sided PICC 
line. The lungs remain clear with no focal consolidation to 
suggest pneumonia. Central pulmonary vasculature is full but 
less so than on the ___ film and no peripheral edema is 
evident. 
 
Brief Hospital Course:
___ HOSPITAL COURSE

Mr. ___ was admitted to the neurology ICU after being found to 
have a basilar artery thrombus resulting ___ several small 
ischemic strokes, ___ the bilateral cerebellar hemispheres as 
well as a right thalamic infarct, and question of right 
transverse sinus thrombosis on MRV (now thought to simply be a 
fenestration).

He was started on a heparin gtt for PTT goal of 50-70. He was 
placed with HOB flat with goal BP 140-180. He did well 
initially, on exam with gaze-evoked nystagmus bilaterally, and 
bilateral ataxia, although full strength. However, around 5pm on 
the day of admission, he was found to be somnolent with new 
onset skew deviation (left eye down and right eye with severely 
restricted eye movements), pinpoint pupils and left-sided 
weakness. Neosynephrine was started for goal SBP 180-200. He was 
taken for STAT NCHCT and CTA and neurosurgery was called. NCHCT 
showed new midbrain/pontine infarcts, and CTA was unchanged. 
Neurosurgery did not want to intervene given the time frame 
since onset and the very high risk of embolizing more thrombus 
with manipulation.  Lipid panel showed LDL 81. HbA1c 7.0%. TTE 
wnl.

___ the setting of the new infarct, he developed worsening 
repiratory status and by ___ had acute desaturations to the ___ 
requiring intubation.  BAL done on ___ grew out pan-sensitive 
coag positive staph aureus and he was placed on IV antibiotics 
(vanc/cefepime weaned to levofloxaxin)  He remained intubated on 
minimal ventilator settings but an attempt at extubation ___ 
failed.  He is s/p trach/PEG on ___.  

He was off pressor since ___, maintaining sBP > 140's.  Exam 
continued to improve and he was transferred to the floor on ___. 
  

========================================

STROKE NEUROLOGY FLOOR COURSE (by systems)

# NEUROLOGY: 
With regards to his stroke, he continued to show improvement 
with signs of subtle movement on the left side.  He would also 
engage with the examiner (please see above for most recent 
exam).  For anticoagulation, he was maintained on heparin gtt 
(PTT goal 50-70) and coumadin was started with first dose given 
___.  His INR was 1.9 on discharge (not at goal of ___.  PLease 
stop heparin once INR ___. His blood pressure goals were 
liberalized to 110-180 and he did not require medications to 
achieve this.  His activity level was liberalized as well. His 
atorvastatin was continued.  

# ___ :
His home antihypertensives were not restarted give liberal blood 
pressure goals of 110-180.  He was maintained on atorvastatin.  
Systemic anticoagulation as described above.

# PULMONARY: 
Trach was placed ___ ICU. His Levofloxacin was continued to treat 
his known MSSA PNA.  This should continue through ___. 

# ID: 
He did spike a fever on ___ (with leukocytosis that had remained 
___ during entire hospital course).  Repeat panculture and CXR 
did not show new infection and PNA was not seen on CXR.  
Antibiotics were not rebroadened and there were no subsequent 
fevers.  He continued on Levofloxacin at time of discharge.  
Blood cultures were negative x 48hrs at time of discharge (other 
work-up returned negative as final result). 

# NUTRITION: PEG was placed ___ ICU.  He continued to tolerate 
tube feeds 

# ACCESS: PICC on right arm

=============================================

TRANSITIONAL ISSUES: 
1) Continue heparin gtt with goal PTT 50-70 as part of a bridge 
to therapeutic INR (___).  Once INR therapeutic, please STOP 
heparin drip.
2) Please check INR daily until 3 consecutive INRs are between 
___ and then can check INR every third day. 
3) Continue levofloxacin through ___ for treatment of MSSA PNA
4) Respiratory care for trach
5) Tube feeding recommendations are enclosed ___ this packet
6) Stroke neurology follow-up with Dr. ___.
     Department: NEUROLOGY
     When: ___ at 2:00 ___
     With: ___
     Building: ___
     Campus: ___ Best Parking: ___

====================================================

AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic 
Attack

1. Dysphagia screening before any PO intake? (x) 
2. DVT Prophylaxis administered by the end of hospital day 2? 
(x) Yes 
3. Antithrombotic therapy administered by end of hospital day 2? 
(x) Yes 
4. LDL documented (required for all patients)? (x) Yes (LDL = 
81) 
5. Intensive statin therapy administered? (x) Yes atorvastatin 
40mg 
6. Smoking cessation counseling given? (x) No [if no, reason: 
(x) non-smoker 
7. Stroke education given (written form ___ the discharge 
worksheet)? (x) Yes (stroke education = personal modifiable risk 
factors, how to activate EMS for stroke, stroke warning signs 
and symptoms, prescribed medications, need for followup)
8. Assessment for rehabilitation or rehab services considered? 
(x) Yes 
9. Discharged on statin therapy? (x) Yes 
10. Discharged on antithrombotic therapy? (x) Yes - systemic 
Anticoagulation
11. Discharged on oral anticoagulation for patients with atrial 
fibrillation/flutter? (x) Yes 
====================================================
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atenolol 50 mg PO DAILY 
2. lisinopril-hydrochlorothiazide 40-25 mg oral DAILY 
3. MetFORMIN (Glucophage) 500 mg PO BID 
4. Aspirin 325 mg PO DAILY 

 
Discharge Medications:
1. Acetaminophen 325-650 mg PO Q6H:PRN pain/fever 
2. Atorvastatin 40 mg PO DAILY 
3. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID 
4. Docusate Sodium 100 mg PO BID constipation 
5. Heparin IV 
     No Initial Bolus
     Initial Infusion Rate: 2100 units/hr
     Start: ___, First Dose: 1600 
     Check PTT Q6hrs. Goal 50-70. 
6. Insulin SC Sliding Scale Fingerstick QACHS, HS
       Insulin SC Sliding Scale using REG Insulin
7. Levofloxacin 750 mg IV Q24H Duration: 3 Days Through ___. Milk of Magnesia 30 mL PO Q6H:PRN constipation 
9. Nystatin Oral Suspension 5 mL PO QID 
10. Senna 8.6 mg PO BID constipation 
11. Warfarin 7.5 mg PO DAILY16 
 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
- Basilar thrombosis 
- Ischemic stroke (infarcts ___ the cerebellum, pons, and 
midbrain)
- MSSA pneumonia
- Hypertension
- Diabetes mellitus
 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Mr. ___,

You were hospitalized due to symptoms of slurred speech, 
dizziness, difficulty moving your eyes, and left sided weakness. 
These symptoms were the result of an ACUTE ISCHEMIC STROKE, a 
condition ___ which a blood vessel providing oxygen and nutrients 
to the brain is blocked by a clot. The brain is the part of your 
body that controls and directs all the other parts of your body, 
so damage to the brain from being deprived of its blood supply 
can result ___ a variety of symptoms.

Stroke can have many different causes, so we assessed you for 
medical conditions that might raise your risk of having stroke. 
___ order to prevent future strokes, we plan to modify those risk 
factors. Your risk factors are:
High blood pressure
High cholesterol
Diabetes

We are changing your medications as listed below. 

Please take your other medications as prescribed.

Please follow up with Neurology and your primary care physician 
as listed below.

If you experience any of the symptoms below, please seek 
emergency medical attention by calling Emergency Medical 
Services (dialing 911). ___ particular, since stroke can recur, 
please pay attention to the sudden onset and persistence of 
these symptoms:
- sudden partial or complete loss of vision
- sudden loss of the ability to speak words from your mouth
- sudden loss of the ability to understand others speaking to 
you
- sudden weakness of one side of the body
- sudden drooping of one side of the face
- sudden loss of sensation of one side of the body
- sudden difficulty pronouncing words (slurring of speech)
- sudden blurring or doubling of vision
- sudden onset of vertigo (sensation of your environment 
spinning around you)
- sudden clumsiness of the arm and leg on one side or sudden 
tendency to fall to one side (left or right)
- sudden severe headache accompanied by the inability to stay 
awake

It was a pleasure providing you with care during this 
hospitalization.

 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=16053405-DS-21 | hadm_id=20691165

 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
simvastatin
 
Attending: ___.
 
Chief Complaint:
Abdominal hematoma
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ on Coumadin for hx of recurrent CVAs, most recently R
ponto-medullary infarct who initially was scheduled to undergo
left inguinal hernia repair on ___ with pre-operative
Coumadin to ___ who now presents with 11cm right 
sided
anterior rectus sheath hematoma. Patient was evaluated for
___ for left inguinal incarcerated hernia, which was reduced
and subsequently followed in general surgery clinic. As noted
earlier, he initially had an elective repair scheduled on
___ with Dr. ___. He was taken off Coumadin on ___, and started on Lovenox injections BID. Patient noticed
a small subcutaneous hematoma on ___, which progressively
enlarged into ___. He presented to the ED on 
___
with these complaints and was found to have a stable Hct of 39,
ultrasound was done in the ED demonstrating a 8.8 cm collection
in the right lower abdomen. Patient was discharged from the ED.
However, patient's wife states that there was progression in the
hematoma, with new overlying ecchymosis. 
 
Past Medical History:
- Basilar thrombosis with resultant infarcts in the cerebellum,
pons, and midbrain
- Hypertension
- Diabetes mellitus
- HLD
 
Social History:
___
Family History:
- No h/o strokes, clotting disorders
- Mother died of lung Ca (smoker)
 
Physical Exam:
Physical exam on admission:
Vitals: Stable
General: AAOx3
HEENT: EOMI
Cardiac: Normal S1, S2
Respiratory: Breathing comfortably on room air
Abdomen: Tense right abdomen, with overlying ecchymosis, left
abdomen soft. No rebound or guarding

Discharge Physical Exam:
VS: 98.2, 73, 106/62, 18, 98%ra
GEN: AA&O x 3, NAD, calm, cooperative. +dysarthria & dysphonia
CHEST: Clear to auscultation bilaterally, occasional cough
ABDOMEN: Right medial abdominal hematoma, decreasing in size 
from outline, fading ecchymosis, firm and tender on palpation 
but improved per patient
EXTREMITIES: Warm, well perfused, pulses palpable, - edema
 
Pertinent Results:
___ 07:15AM BLOOD Hct-31.5*
___ 03:45PM BLOOD Hct-33.1*
___ 10:15AM BLOOD WBC-7.5 RBC-3.74* Hgb-11.1* Hct-34.2* 
MCV-91 MCH-29.7 MCHC-32.5 RDW-12.5 RDWSD-41.8 Plt ___
___ 05:21AM BLOOD WBC-8.0 RBC-3.60* Hgb-10.9* Hct-33.1* 
MCV-92 MCH-30.3 MCHC-32.9 RDW-12.7 RDWSD-42.5 Plt ___
___ 10:40PM BLOOD WBC-7.9 RBC-3.99* Hgb-12.0* Hct-36.8* 
MCV-92 MCH-30.1 MCHC-32.6 RDW-12.5 RDWSD-41.7 Plt ___
___ 06:15AM BLOOD WBC-7.7 RBC-4.27* Hgb-12.8* Hct-39.1* 
MCV-92 MCH-30.0 MCHC-32.7 RDW-12.4 RDWSD-41.3 Plt ___
___ 10:40PM BLOOD Glucose-103* UreaN-13 Creat-0.8 Na-145 
K-4.1 Cl-109* HCO3-30 AnGap-10
___ 06:15AM BLOOD Glucose-89 UreaN-12 Creat-0.6 Na-142 
K-3.3 Cl-109* HCO3-29 AnGap-7*

___ Abdominal US
Complex multiloculated fluid collection largely subcutaneous 
collection measures up to 8.8 cm in the right lower quadrant and 
appears to extend deep within anterior abdominal wall soft 
tissues.  This likely represents hematoma although 
infection/superinfection cannot be excluded. 

___ Abd CT
Large right anterolateral abdominal wall subcutaneous tissue 11 
cm hematoma with associated induration of surrounding 
subcutaneous tissues which extends posteriorly along the right 
flank.  There is no intra-abdominal extension. 

 
Brief Hospital Course:
The patient was admitted to the General Surgical Service on 
___ for evaluation and treatment of an abdominal hematoma.  
Admission  abdominal/pelvic CT revealed a large right 
anterolateral abdominal wall subcutaneous tissue 11 cm hematoma 
but had no intra-abdominal extension. The patient was 
hemodynamically stable. He was admitted for serial HCTs 
(36.8->33) with the plan to transfuse if hemodynamically 
unstable or hematocrit continued to drop, with possible ___ 
angiogram to find source. 
.
Hematocrit was stable and the patient remained stable with no 
signs of ongoing bleeding. Coumadin was restarted. Diet was 
progressively advanced as tolerated to a regular diet with good 
tolerability. The patient voided without problem. During this 
hospitalization, the patient was seen by Physical Therapy, who 
cleared him to be discharged home with home ___. The patient was 
adherent with respiratory toilet and incentive spirometry, and 
actively participated in the plan of care with the help and 
support of his wife. ___ boots were used during this stay.
.
At the time of discharge, the patient was doing well, afebrile 
with stable vital signs. The site of the abdominal hematoma was 
softer than on admission with slowly resolving ecchymosis. The 
patient was tolerating a regular diet, at his baseline of 
activity, voiding without assistance, and denied pain.  The 
patient was discharged home with ___ services and would resume 
his normal INR monitoring. The patient and his wife received 
discharge teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atenolol 50 mg PO DAILY 
2. Atorvastatin 40 mg PO QPM 
3. Warfarin 3 mg PO 3X/WEEK (___) 
4. Warfarin 6 mg PO 3X/WEEK (___) 
5. Lisinopril 20 mg PO DAILY 
6. Nuedexta (dextromethorphan-quinidine) ___ mg oral BID 
7. Glycopyrrolate 1 mg PO TID 
8. Doxazosin 4 mg PO HS 
9. ClonazePAM 0.5 mg PO DAILY 

 
Discharge Medications:
1. Atenolol 50 mg PO DAILY 
2. Atorvastatin 40 mg PO QPM 
3. ClonazePAM 0.5 mg PO DAILY 
4. Doxazosin 4 mg PO HS 
5. Glycopyrrolate 1 mg PO TID 
6. Lisinopril 20 mg PO DAILY 
7. Nuedexta (dextromethorphan-quinidine) ___ mg oral BID 
8. Warfarin 3 mg PO 2X/WEEK (MO,TH) 
9. Warfarin 6 mg PO 5X/WEEK (___) 
10. Acetaminophen 650 mg PO Q6H:PRN pain 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Abdominal wall hematoma

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Mr. ___,

You were admitted to ___ for 
management of a hematoma of your abdominal wall after Lovenox 
injections. We monitored your blood count and exam, and you 
remained stable. We restarted your Coumadin on ___ at your 
home dose. You have had no episodes of bleeding and are ready 
for discharge home. 

Please follow these instructions to ensure an uneventful and 
speedy recovery:

*AVOID any activity that may cause injury to your abdominal area 
for the next ___ weeks.
 
*If you suddenly become dizzy, lightheaded, feeling as if you 
are going to pass out go to the nearest Emergency Room as this 
could be a sign that you are having more bleeding in your 
abdominal wall.

Please call your doctor or nurse practitioner or return to the 
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or 
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your 
medications.
*You are getting dehydrated due to continued vomiting, diarrhea, 
or other reasons. Signs of dehydration include dry mouth, rapid 
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a 
bowel movement.
*You experience burning when you urinate, have blood in your 
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone 
within 24 hours. Call or return immediately if your pain is 
getting worse or changes location or moving to your chest or 
back.
*You have shaking chills, or fever greater than 101.5 degrees 
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern 
you.

Please resume all regular home medications, unless specifically 
advised not to take a particular medication. Also, please take 
any new medications as prescribed.

Please get plenty of rest, continue to ambulate several times 
per day, and drink adequate amounts of fluids. Avoid lifting 
weights greater than ___ lbs until you follow-up with your 
surgeon.

Avoid driving or operating heavy machinery while taking pain 
medications.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=16053405-DS-23 | hadm_id=23029881

 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
simvastatin
 
Attending: ___.
 
Chief Complaint:
Bridging anticoagulation 
 
Major Surgical or Invasive Procedure:
___: Left and right medialization laryngoplasty with Gore-Tex
___: Open exploration of neck and evacuation of hematoma

 
History of Present Illness:
___ is a ___ man with HTN, s/p CVA with resultant hemiplegia 
and pseudobulbar and bulbar findings also with dysarthria and 
dysphasia, bilateral vocal fold atrophy, a right vocal fold 
paresis, secondary muscle tension dysphonia who needs ENT 
surgical intervention on ___. He is directly admitted to 
medicine for bridging anticoagulation prior to planned surgery 
on ___. Reportedly, unable to do Lovenox so admitted for 
Heparin infusion. His last dose of Warfarub was ___ 
and his last INR was ___ yesterday checked at home.
 
He has no significant complaints at this time. No fevers, 
chills, nausea, vomiting, bleeding or bruising. Wife reports 
diarrhea recently. 
 
Review of systems:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, sinus tenderness, rhinorrhea or 
congestion. Denies cough, shortness of breath. Denies chest pain 
or tightness, palpitations. Denies nausea, vomiting, 
constipation or abdominal pain. No dysuria. Denies arthralgias 
or myalgias. Otherwise ROS is negative.
   
                                                    

 
Past Medical History:
*S/P STROKE                                                     
DYSARTHRIA                                                      
DYSPHAGIA                                                       
HEMIPLEGIA                                                      
HYPERTENSION                                                    
SNORING                                                         
NEUROPATHY                                                      
PUPULAR LESION                                                  
HOME SERVICES                                                   
ADVANCE CARE PLANNING                                           
H/O NEPHROLITHIASIS                                             
H/O DIABETES TYPE II                                            
H/O HYPERTRIGLYCERIDEMIA                                        
H/O OBESITY                                                     
H/O REHAB   
 
Social History:
___
Family History:
Mother   ___     LUNG CANCER  in ___, smoker; TRANSIENT 
ISCHEMIC  ATTACK    
 
Physical Exam:
ADMISSION EXAM:
Vitals: 97.8 ___ / 91 58 18 93 RA 
Pain Scale: ___
General: Patient appears overall well, chronically debilitated 
but not acutely unwell. Alert, oriented and in no acute distress 
 
HEENT: Sclera anicteric, MMM, poor dentition, oropharynx clear  
Neck: supple, JVP low, no LAD appreciated
Lungs: Clear to auscultation bilaterally, moving air well and 
symmetrically, no wheezes, rales or rhonchi appreciated  
CV: Regular rate and rhythm, S1 and S2 clear and of good 
quality, no murmurs, rubs or gallops appreciated
Abdomen: soft, non-tender, non-distended, normoactive bowel 
sounds throughout, no rebound or guarding
Ext: Warm, well perfused, full distal pulses, no clubbing, 
cyanosis or edema    
Neuro: Slow speech with dysphonia, alert and oriented x 3. 
Severe dysarthria. Right eye with eye patch. INtact strength on 
the right side although some limitation in proximal movement of 
the right arm. Nrisk reflexes 3+ on the left leg, but no clonus. 
Decreased sensation with left arm.

DISCHARGE EXAM: 
Vital Signs:  AF 110s-140s/70s-80s ___ 92-98% on 3L
Tele: rates now ___
GEN: Alert, NAD
HEENT: Baseline mild L facial droop
NECK: dressing surrounding neck c/d/i, ecchymosis surrounding 
prior drain site, steristrips
CV: RRR, no m/g/r
PULM: expiratory rhonchi vs upper airway sounds, with air entry 
bilaterally
GI: S/NT/ND
Extr: no edema
NEURO: Baseline L sided hemiparesis; Notable dysphonia and 
dysarthria
PSYCH: normal range of affect
 
Pertinent Results:
ADMISSION LABS:
___ 10:45PM BLOOD WBC-7.1 RBC-4.42* Hgb-13.2* Hct-40.4 
MCV-91 MCH-29.9 MCHC-32.7 RDW-12.8 RDWSD-42.8 Plt ___
___ 10:45PM BLOOD ___ PTT-36.3 ___
___ 10:45PM BLOOD Glucose-169* UreaN-15 Creat-0.8 Na-144 
K-3.2* Cl-106 HCO3-26 AnGap-12
___ 10:45PM BLOOD Calcium-8.9 Phos-3.0 Mg-1.8

DISCHARGE LABS:
___ 07:40AM BLOOD WBC-11.2* RBC-4.19* Hgb-12.6* Hct-38.7* 
MCV-92 MCH-30.1 MCHC-32.6 RDW-12.8 RDWSD-43.1 Plt ___
___ 07:40AM BLOOD ___
___ 07:40AM BLOOD Glucose-87 UreaN-10 Creat-0.6 Na-145 
K-3.9 Cl-103 HCO3-31 AnGap-11

WBC trend:
7 -> 7 -> 16 -> 16 -> 13 -> 12 -> 8 -> 10 ->11

CXR (___) - IMPRESSION: 
In comparison with the study of ___, there are 
lower lung
volumes.  Cardiac silhouette is within normal limits and there 
is minimal
indistinctness of pulmonary vessels that could represent small 
of a shin in
pulmonary venous pressure.  Opacification at the left base most 
likely
represents atelectatic changes with possible small effusion.

CXR (___) - FINDINGS:
Over left lower lung field increased opacification is seen 
concerning for
aspiration or worsening pneumonia
No signs of pulmonary edema.
The cardiomediastinal silhouette is within normal limits .
No pleural effusion.
IMPRESSION:
Left lower lung opacification concerning for aspiration / 
pneumonia.

 
Brief Hospital Course:
___ y/o M with PMHx HTN, s/p CVA with resultant hemiplegia and 
pseudobulbar and bulbar findings also with dysarthria and 
dysphasia, bilateral vocal fold atrophy, a right vocal fold 
paresis, secondary muscle tension dysphonia who was admitted for 
bridging anticoagulation with heparin gtt in the setting of 
planned ENT surgical intervention on ___. Post-operative course 
complicated by bleeding and hematoma formation, requiring return 
to the OR, as well as overt aspiration. Despite recommendations 
for NG or PEG for alternative feeding route, the patient 
adamantly declined, as he had these in the past and it was not 
consistent with his goals of care. This was discussed 
extensively with him and his wife on numerous occasions.

# PRIOR BRAINSTEM STROKE / VOCAL CORD ATROPHY: With hemiplegia, 
bulbar and pseudobulbar findings, as well as bilateral vocal 
cord atrophy and right vocal cord paresis, admitted for planned 
medialization laryngoplasty left and right. He was admitted for 
perioperative bridging with heparin gtt. Underwent bilateral 
medialization laryngoplasty ___. Was placed back on heparin gtt 
and Coumadin post-operatively; however, this was complicated by 
bleeding / hematoma. He is now s/p evacuation of hematoma and JP 
drain placement. H/H since stable. He was restarted on 
anticoagulation and bridged back to coumadin. He received 1 week 
of augmentin/unasyn post-op. His drain was pulled on ___. He 
continued to struggle with phonation post-op, although this may 
improve over time per ENT. He will f/u with ENT in clinic. He 
has steristrips in place, which will fall off over time. 

#Anticoagulation:
Became supratherapeutic (3.3 from 2.0 the prior day) once 
restarted on home coumadin dose (6 mg 4x weekly, 3 mg 3x 
weekly). Coumadin held on ___ and restarted at 3 mg on  ___. 
INR 2.7 on ___. Antibiotics and being NPO probably contributed. 
Patient has home POC INR machine at home and will titrate 
closely, working with ___ clinic. For now recommended 3 mg 
daily, although pending values over upcoming days may return to 
closer to home dosing.

# ASPIRATION: Noted to have several episode of coughing and 
severe desaturation after eating. He was seen by ___ who noted 
aspiration and recommended NPO. The patient was not in agreement 
with NGT or PEG. Therefore, he was placed on IVFs while NPO. No 
significnt suspicion for pneumonia, likely because patient 
already on augmentin at time of aspiration event and lacked a 
clinical picture suggestive of infection. Swallowing was 
reassessed after several days but not found to be improved. 
Patient preferred to eat with risk of aspiration rather than 
consider feeding tube. Made recommendations for safest modified 
diet considering this preference after multiple extensive 
discussions (honey/ground diet, aspiration precautions, 
continued SLP therapy at home)

# HYPERTENSION
# Bradycardia
Continued lisinopril. Atenolol reduced from 50 to 25 due to 
bradycardia, which subsequently improved from ___ to 
___. BP remained in 110s-150s, may need further titration as 
outpatient.

# HLD: On statin.

#Thrombocytopenia:
Mild. Slightly improved during admission. Follow-up as 
outpatient

#Leukocytosis:
Worsening on HD3, subsequently improved although mildly elevated 
at time of discharge. Low suspicion for infection. Can monitor 
as outpatient

========================================
Transitional issues:
(1) close monitoring of INR and close communication with 
___ clinic about dose adjustments (patient checks INR at 
home with POC machine and discusses with ___ clinic) - for 
now is on 3 mg daily, but will likely require uptitration back 
toward prior dosing of ___
(2) honey thickened/ground diet, aspiration precations, home SLP 
therapy. Contined discssions as outpatient abot goals of care 
and nutrition.
(3) follow-up with primary care scheduled and ENT follow-p to be 
schedled
(4) repeat CBC in follow-up given mild thrombocytopenia and mild 
lekocytosis
(5) evaluation of drain wound (R neck) in follow-up; steristrips 
can be allowed to fall off on their own

========================================
>30 minutes spent in patient care and coordination of discharge 
on day of discharge

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Doxazosin 4 mg PO HS 
2. Lisinopril 40 mg PO DAILY 
3. Glycopyrrolate 1 mg PO TID:PRN secretions 
4. ClonazePAM 0.5 mg PO QHS 
5. Atenolol 50 mg PO QHS 
6. dextromethorphan-quinidine ___ mg oral BID 
7. Warfarin 6 mg PO 4X/WEEK (___) 
8. Warfarin 3 mg PO 3X/WEEK (___) 
9. Atorvastatin 40 mg PO QPM 
10. Ketoconazole Shampoo 1 Appl TP ASDIR 
11. Docusate Sodium 100 mg PO BID 

 
Discharge Medications:
1.  Atenolol 25 mg PO QHS  
2.  Warfarin 3 mg PO DAILY16  
3.  Warfarin 3 mg PO DAILY16  
4.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
5.  Atorvastatin 40 mg PO QPM  
6.  ClonazePAM 0.5 mg PO QHS  
7.  dextromethorphan-quinidine ___ mg oral BID  
8.  Docusate Sodium 100 mg PO BID:PRN constipation  
9.  Doxazosin 4 mg PO HS  
10.  Glycopyrrolate 1 mg PO TID:PRN secretions  
11.  Ketoconazole Shampoo 1 Appl TP ASDIR  
12.  Lisinopril 40 mg PO DAILY  
13.  nystatin 100,000 unit/gram topical BID  
14.Home Oxygen
Home O2.  Length of need for O2: 99 months. 2 L continuous O2 at 
rest and with ambulation. Include concentrator and portables. 
Diagnosis hypoxia: 799.02. 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
History of stroke
Vocal Cord Atrophy / Paresis
Aspiration/Dysphagia
Hypoxia
Low platelets
Low heart rate

 
Discharge Condition:
Alert and interactive, but with significant dysphonia. Reduced 
functional status from his baseline. Hemodynamically stable. 

 
Discharge Instructions:
You presented to the hospital for heparin bridging in 
anticipation of your planned ENT surgery. Your postoperative 
course was complicated by bleeding requiring repeat surgery. 
Your course was also complicated by episodes of aspiration. 
Because of this aspiration, you were made NPO and placed on IV 
fluids. After several days, we reassessed your swallowing and 
found that you were still aspirating. Based on your preference 
to absolutely avoid a feeding tube of any sort and to take the 
risk of aspirating with eating food, we recommended that you 
take a modified diet with honey thickened liquids and ground 
solids. We also recommend supplemental oxygen until your oxygen 
levels have recovered.

You INR rose very quickly when restarted on coumadin, most 
likely because of your antibiotics and reduced oral intake. 
Therefore for now we have reduced your dosing to 3 mg daily. 
However this will likely be increased in the future, and over 
the next ___ weeks you should monitor closely and be in close 
communication with your ___ clinic. 

Of note we reduced your atenolol dose due to low heart rates. 
Your blood pressures have been overall in a reasonable range 
despite this change, but you should continue monitoring the 
blood pressure and if elevated then you may need a different 
blood pressure medication instead.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=16053405-DS-20 | hadm_id=23860278

 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
simvastatin
 
Attending: ___.
 
Chief Complaint:
weakness, dysarthria
 
Major Surgical or Invasive Procedure:
PEG placement

 
History of Present Illness:
per Dr. ___ admission note:
Mr. ___ is a ___ M w PMHx of HTN, HLD, DM, and basilar 
thrombosis with resultant infarcts in the cerebellum, pons, and 
midbrain ___ ___ who is transferred to ___ for new 
worsening dysarthria and right sided weakness.

Mr. ___ was hospitalized at ___ from ___ to ___ 
after presenting with a basilar artery thrombus resulting in 
several small ischemic strokes in the bilateral cerebellar 
hemispheres and R thalamus. During that complicated hospital 
stay, Mr. ___ was initially managed in the ICU with 
anticoagulation for his basilar artery thrombus. Unfortuantely, 
he developed new mibrain and pontine infarctions. He was 
severely debilited and underwent trach and PEG on ___. He was 
discharged on coumadin for his basilar artery thrombus. He was 
then switched to apirin 325mg one month ago after a repeat CTA 
was stable.  
Mr. ___ is accompanied by his wife, who provides the below 
history. She states that on ___, Mr. ___ had an episode of 
diarrhea but was otherwise well. The diarrhea persisted on ___ 
and he asked to take a nap in the early afternoon. When he awoke 
from his nap, his wife noted that he appeared generally weaker 
and had difficulty eating his lunch - it took a great effort to 
chew and swallow and he was also drooling quite a bit. She also 
notes that his speech was ever so slightly more dysarthric (she 
can usually understand approximately 90% of what he says, on 
___ it was 80%). Mr. ___ also complained of a headache a 
that time which is very unusual for him. Ms. ___ then called 
EMS, and Mr. ___ presented to ___ with 
worsening dysarthria and weakness. A ___ performed in the ED 
there was without hemorrhage or obvious signs of new stroke. He 
was admitted to the hospital after neurology noted chronic L 
sided weakness and new RUE/RLE UMN weakness and noted they 
recommended an MRI for further evaluation.  

On the morning of ___, Mrs. ___ states that she thinks Mr. 
___ was ever so slightly improved from the day prior. He was 
able to take is breakfast without too much difficult and he did 
well working with ___. His speech was also nearly back to 
baseline. She does note that he had a low grade temperature that 
day to 100.7.

At around noon, however, she noticed a worsening in Mr. ___ 
condition. He was drooling, unable to chew his lunch, and unable 
to suck through a straw for liquids. She also reports that his 
speech began to get much worse at this time. From noon until 4PM 
he continued to worsen, becoming weaker and more dysarthric. She 
estimates that at its worst, she could only understand 10% of 
what he was saying at that he was speaking one word or even one 
letter at a time.

Mr. ___ did have an MRI at ___ at approximately 
4PM on ___. MRI demonstrated show new small L midbrain 
infarct; MRA redemonstrated know cerebrovascular disease. He was 
subsequently transferred to ___ as he has received his prior 
neurology care here.

Mr. ___ is unable to participate in full ROS, pertinent 
findings are noted above.
 
Past Medical History:
- Basilar thrombosis with resultant infarcts in the cerebellum,
pons, and midbrain
- Hypertension
- Diabetes mellitus
- HLD
 
Social History:
___
Family History:
- No h/o strokes, clotting disorders
- Mother died of lung Ca (smoker)
 
Physical Exam:
===========
ADMISSION EXAM
===========
VS T98.2 BP186/115 HR85 RR22 Sat93%RA
GEN - Awake, cooperative, 
HEENT - NC/AT, eye patch over R eye, preferentially rotates head
~30 degrees to his left, thick secretions in oropharynx
NECK - Supple, no nuchal rigidity
RESP - +upper airway noise
CV - RRR, warm and well perfused
ABD - soft, nontender, nondistended
SKIN - red ?petechial rash over R hand
 
Neurologic Exam:

MENTAL STATUS
Alert and oriented x3. Severe dysarthria limits ability to
participate in history or give verbal responses during
examination. Speech is slow and slurred, c/b inability to clear
secretions. Does provide additional history detail and wife
reports no concerns regarding his MS.

___ NERVES
II: PERRL 2->1mm and brisk bilaterally. VFF to confrontation. 
III, IV, VI: R eye w restricted ROM in all directions, L eye
unable to abduct or adduct fully (new)
V: Facial sensation intact to light touch, temperature
VII: ?new R lower facial droop
VIII: Hearing intact to voice
IX, X: ?decreased elevation of R palate
XI: ___ strength in SCM bilaterally
XII: Tongue protrudes in right of midline but has full ROM
 
MOTOR
Increase tone in LUE and LLE. Decreased tone in RUE and RLE.
 Delt Bic Tri WrE FFl FE   IP Quad Ham TA ___
L  ___  ___   4+   5   4+  5    5     5 
R  ___  ___   3    ___    5     5 
 
REFLEXES
    Bi  Tri  ___  Pat  Ach
L   2+   2+    2+    2    3 ___ beats of clonus)
R   2+   2+    2+    2    1
- Toes are upgoing bilaterally
- Pectoralis Jerk absent, crossed adductors are absent 
- +R grasp
 
SENSORY:
Difficult to assess in patient with severely impaired 
communication. Responds to light touch throughout. ?Decreased 
sensation with some allodynia on the left arm.

COORDINATION:
+Dysmetria with L FNF, per wife: "worse than baseline". Also 
dysmetric on the R, but complicated by weakness.

GAIT: wheelchair bound

=================================
Discharge physical exam = Awake & alert. Sitting in bed wearing 
eye patch ___ diplopia. Emotially lable & cries easily. 
Dysarthric/anarthric. Limited abduction of the left eye. Left 
eye down & in at rest. Flat left NLF. Lt UE ___ ___ ___ 
distally. Lt ___ ___ ___ ___ distally. Moves Rt side well. + 
BS. Mild abdominal tenderness. PEG site clean. No tenderness.
 
Pertinent Results:
ADMISSION LABS:
___ 01:31AM BLOOD WBC-11.1*# RBC-4.39* Hgb-13.3* Hct-37.5* 
MCV-86 MCH-30.3 MCHC-35.4* RDW-13.3 Plt ___
___ 01:31AM BLOOD Neuts-81.9* Lymphs-10.4* Monos-6.0 
Eos-1.4 Baso-0.2
___ 01:31AM BLOOD ___ PTT-32.4 ___
___ 01:31AM BLOOD Glucose-115* UreaN-7 Creat-0.7 Na-144 
K-2.8* Cl-106 HCO3-25 AnGap-16
___ 01:31AM BLOOD ALT-12 AST-15 CK(CPK)-74 AlkPhos-79 
TotBili-1.3
___ 01:31AM BLOOD Calcium-9.2 Phos-3.5 Mg-1.8 

DISCHARGE LABS: 
___ 04:08AM BLOOD WBC-10.5 RBC-4.36* Hgb-13.3* Hct-38.7* 
MCV-89 MCH-30.4 MCHC-34.3 RDW-13.7 Plt ___
___ 04:08AM BLOOD ___ PTT-58.4* ___
___ 04:08AM BLOOD Glucose-123* UreaN-18 Creat-0.7 Na-141 
K-3.5 Cl-103 HCO3-32 AnGap-10

STROKE RISK FACTORS:
Cholest-66
Triglyc-83 
HDL-24 
CHOL/HD-2.8 
LDLcalc-25

%HbA1c-5.7 eAG-117
TSH-1.1

IMAGING:
MR/MRA head (___)
IMPRESSION: 
1. Slightly increased size of the brainstem infarct compared to 
MRI from ___, with a new area of infarct just 
inferior to the pons in the right pontomedullary junction 
(series 6, image 8).
2. Limited MRA due to patient motion. Occlusion of the basilar 
artery and near complete occlusion of the V4 segment of the left 
vertebral artery are similar to MRA from ___. The 
superior cerebellar and posterior cerebral arteries are not 
visualized on the current MRA, although resolution is limited on 
the current study and no infarcts are identified within these 
territories on current MRI. If there is a need to evaluate the 
intracranial vasculature with better resolution, CTA could be 
considered.

XR Elbow (___)
FINDINGS: 
 
There is soft tissue swelling over the olecranon.  This is 
nonspecific but could reflect olecranon bursitis.  Lateral view 
is oblique, limiting assessment for joint effusion. No acute 
fracture or bone lesion is seen. Joint spaces appear preserved.

 
Brief Hospital Course:
# NEURO: ___ was transferred from ___ with 
symptoms of worsening dysarthria and a new pontine stroke 
demonstrated on MRI. His symptoms were at first attributed to 
hypoperfusion due to hypotension in the setting of known basilar 
artery thrombus, but upon review of records from his 
hospitalization prior to transfer there was no recorded 
hypotension. Despite maintaining permissive hypertension during 
the current admission he had the subsequent expansion of his 
infarct, demonstrated on repeat MRI. He was thus started on 
heparin gtt as bridge to coumadin. He will need to remain on 
coumadin until his outpatient Vascular Neurology followup. His 
risk factors were again measured and his LDL was 25 and A1c was 
5.7%. He failed his swallow study due to severe dysphagia so a 
PEG tube was placed. He was evaluated by ___ and OT who 
recommended acute rehab to address his right sided weakness and 
ataxia as well as his severe dysarthria. On ___ he started 
Coumadin, but will be discharged to rehab on heparin drip (goal 
PTT 50-70, no boluses) until INR therapeutic. His home Aspirin 
325mg daily was stopped in hospital due to alternate use of 
anticoagulation; will consider restarting at outpatient 
neurology follow-up. 

# CARDIOVASC: Permissive hypertension was maintained for 
majority of hospitalization, then home meds (lisinopril and 
atenolol) were restarted. On discharge he was still 
intermittently hypertensive to SBP 150s-180s. Thus, increased 
atenolol from 25mg daily to 50mg daily (home dose) on day of 
discharge. Will need BP monitoring at rehab to aim for final 
goal SBP 130-140. 

# PSYCH: Patient was intermittently tearful and depressed during 
hospitalization, with a pseudobulbar affect at time. This may 
have been some degree of post-stroke depression but also suspect 
symptoms are pseudobulbar secondary to involvement of mibrain 
and pons in stroke. Started fluoxetine 10mg daily during 
hospitalization. 

# RHEUM: He developed swelling over his left elbow concerning 
for olecranon bursitis. He was evaluated by rheumatology who 
performed a joint aspiration which confirmed bursitis. This was 
managed with supportive care. 

-----------------
TRANSITIONS OF CARE:
- Needs daily INR monitoring while uptitrating Coumadin 
- Goal SBP 130-140, may need antihypertensives uptitrated, 
increased Lisinopril from 20mg daily to 30mg daily on discharge 
(___)

====================================
AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic 
Attack

1. Dysphagia screening before any PO intake? (x) Yes [performed 
and documented by admitting resident] â () No

2. DVT Prophylaxis administered by the end of hospital day 2? 
(x) Yes - () No

3. Antithrombotic therapy administered by end of hospital day 2? 
(x) Yes - () No

4. LDL documented (required for all patients)? (x) Yes (LDL = 
25) - () No

5. Intensive statin therapy administered? () Yes - (x) No [if 
LDL >= 100, reason not given: ____ ]
(intensive statin therapy = simvastatin 80mg, simvastatin 
80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, rosuvastatin 
20mg or 40mg, for LDL >= 100)

6. Smoking cessation counseling given? () Yes - (x) No [if no, 
reason: (x) non-smoker - () unable to participate]

7. Stroke education given (written form in the discharge 
worksheet)? (x) Yes - () No
(stroke education = personal modifiable risk factors, how to 
activate EMS for stroke, stroke warning signs and symptoms, 
prescribed medications, need for followup)

8. Assessment for rehabilitation or rehab services considered? 
(x) Yes - () No [if no, reason not assessed: ____ ]

9. Discharged on statin therapy? (x) Yes - () No [if LDL >= 100 
or on a statin prior to hospitalization, reason not discharged 
on statin: ____ ]

10. Discharged on antithrombotic therapy? () Yes [Type: () 
Antiplatelet - () Anticoagulation] - () No

11. Discharged on oral anticoagulation for patients with atrial 
fibrillation/flutter? (x) Yes - () No [if no, reason not 
discharge on anticoagulation: ____ ] - () N/A
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atorvastatin 40 mg PO QPM 
2. Doxazosin 4 mg PO HS 
3. Lisinopril 20 mg PO QHS 
4. ClonazePAM 0.5 mg PO QHS 
5. Atenolol 50 mg PO QHS 
6. Aspirin 325 mg PO QHS 
7. Docusate Sodium 100 mg PO DAILY:PRN constipation 

 
Discharge Medications:
1. Atenolol 50 mg PO QHS 
2. Atorvastatin 40 mg PO QPM 
3. ClonazePAM 0.25 mg PO QHS 
4. Acetaminophen 650 mg PO Q6H:PRN pain/fever 
5. Bisacodyl 10 mg PO/PR DAILY:PRN constipation 
6. Fluoxetine 10 mg PO DAILY 
7. Heparin IV 
No Initial Bolus
Initial Infusion Rate: 1800 units/hr
Start: Today - ___, First Dose: 1100 
Goal PTT 50-70. 
NO BOLUSES.  
8. Lansoprazole Oral Disintegrating Tab 30 mg PO DAILY 
9. Miconazole Powder 2% 1 Appl TP BID:PRN rash 
10. Warfarin 5 mg PO DAILY16 
11. Doxazosin 4 mg PO HS 
12. Lisinopril 20 mg PO DAILY 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Basilar artery occlusion with infarction
s/p PEG tube

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

Discharge physical exam = Awake & alert. Sitting in bed wearing 
eye patch ___ diplopia. Emotially lable & cries easily. 
Dysarthric/anarthric. Limited abduction of the left eye. Left 
eye down & in at rest. Flat left NLF. Lt UE ___ ___ ___ 
distally. Lt ___ ___ ___ ___ distally. Moves Rt side well. + 
BS. Mild abdominal tenderness. PEG site clean. No tenderness.

 
Discharge Instructions:
Dear Mr. ___,
You were hospitalized due to symptoms of slurred speech and 
right-sided weakness resulting from an ACUTE ISCHEMIC STROKE, a 
condition in which a blood vessel providing oxygen and nutrients 
to the brain is blocked by a clot. The brain is the part of your 
body that controls and directs all the other parts of your body, 
so damage to the brain from being deprived of its blood supply 
can result in a variety of symptoms.
Stroke can have many different causes, so we assessed you for 
medical conditions that might raise your risk of having stroke. 
In order to prevent future strokes, we plan to modify those risk 
factors. Your risk factors are:
 - basilar artery thrombus
 - high blood pressure
 - high cholesterol
 - diabetes

We are changing your medications as follows:
- restarting coumadin

Please take your other medications as prescribed.

Please followup with Neurology and your primary care physician 
as listed below.

It was a pleasure providing you with care during this 
hospitalization.

 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=16053405-DS-22 | hadm_id=23951249

 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
simvastatin
 
Attending: ___.
 
Chief Complaint:
Left inguinal hernia 
 
Major Surgical or Invasive Procedure:
Left inguinal hernia repair 
 
History of Present Illness:
___ year old  with hx of basilar infarct presenting to the 
hospital for pre operative anticoagulation management. Patient 
had procedure scheduled back in ___ but had to be admitted 
to the hospital due to a 11 cm right rectus sheath hematoma due 
to bridging therapy with lovenox. Patient hematoma is now 
resolving and the patient was advised to discontinue the lovenox 
and restart his Coumadin anticoagulation. The patient prior to 
arrival to the hospital the
Coumadin was holded on ___ as indicated by Dr. ___ in 
his ___ clinic. Patients wife indicates that on the 
morning of admission the patients INR was 1.9

 
Past Medical History:
- Basilar thrombosis with resultant infarcts in the cerebellum,
pons, and midbrain
- Hypertension
- Diabetes mellitus
- HLD
 
Social History:
___
Family History:
- No h/o strokes, clotting disorders
- Mother died of lung Ca (smoker)
 
Physical Exam:
Physical exam:
Vitals: T BP HR RR O2Sat 
General: AAOx3, NAD
HEENT: EOMI, CN ___ intact 
Cardiac: RRR, Normal S1, S2
Respiratory: Breathing comfortably on room air, CTAB
Abdomen: Incision site is non-tender, non-erythematous, and 
flat. Tense right abdomen from previous hematoma but no 
overlying ecchymosis, left abdomen soft. No rebound or guarding. 

Ext: Warm and well perfused. No evidence of cyanosis or 
clubbing. 
 
Pertinent Results:
___ 05:20PM   ___ PTT-37.6* ___
___ 05:20PM   PLT COUNT-185
___ 05:20PM   WBC-6.4 RBC-4.45* HGB-13.3* HCT-41.5# MCV-93 
MCH-29.9 MCHC-32.0 RDW-12.6 RDWSD-43.1
___ 05:20PM   CALCIUM-9.2 PHOSPHATE-3.6 MAGNESIUM-2.0
___ 05:20PM   estGFR-Using this
___ 05:20PM   GLUCOSE-84 UREA N-13 CREAT-0.7 SODIUM-144 
POTASSIUM-3.6 CHLORIDE-107 TOTAL CO2-31 ANION GAP-10
 
Brief Hospital Course:
The patient presented to pre-op on ___ and was started on a 
heparin drip. Once PTT was therapeutic, he was evaluated by 
anesthesia and taken to the operating room for a left inguinal 
hernia repair. There were no adverse events in the operating 
room; please see the operative note for details.  Pt was 
extubated, taken to the PACU until stable, then transferred to 
the ward for observation. He was bridged with heparin onto 
warfarin. On POD #3, patient had an episode of hypotension to 
70/40. He received a 1000 mL LR bolus and blood work was sent 
for CBC and electrolytes. He responded well to the fluid bolus 
and his blood pressure returned to baseline. INR on ___ was 
subtherapeutic on ___, patient was discharged from the 
hospital on a lovenox bridge and will follow up with his primary 
care provider ___ ___.  

Neuro: The patient was alert and oriented throughout 
hospitalization; pain was managed with PO oxycodone.
 
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.

Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet and incentive spirometry were encouraged throughout 
hospitalization. 

GI/GU/FEN: Postoperatively, patient was able to tolerate a 
regular diet. Patient's intake and output were closely 
monitored. On POD #3 patient had an episode of hypotension to 
70/40. He received a 1000 mL bolus of LR, to which he responded 
well and returned to baseline.    

ID: The patient's fever curves were closely watched for signs of 
infection, of which there were none.

HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none. Preoperatively, warfarin 
was held and patient was started on a heparin drip. 
Postoperatively, patient was bridged with heparin back onto 
warfarin and discharged on a lovenox bridge. 

Prophylaxis: The patient received a heparin drip and ___ dyne 
boots were used during this stay.

At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable.  The patient was tolerating a diet, 
voiding without assistance, and pain was well controlled.  The 
patient received discharge teaching and follow-up instructions 
with understanding verbalized and agreement with the discharge 
plan.

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Atenolol 50 mg PO DAILY 
2. Atorvastatin 40 mg PO QPM 
3. ClonazePAM 0.5 mg PO DAILY 
4. Doxazosin 4 mg PO HS 
5. Glycopyrrolate 1 mg PO TID 
6. Lisinopril 20 mg PO DAILY 
7. Nuedexta (dextromethorphan-quinidine) ___ mg oral BID 
8. Warfarin 3 mg PO 2X/WEEK (MO,TH) 
9. Warfarin 6 mg PO 5X/WEEK (___) 
10. Acetaminophen 650 mg PO Q6H:PRN pain 

 
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H:PRN pain 
2. Atenolol 50 mg PO DAILY 
3. Atorvastatin 40 mg PO QPM 
4. ClonazePAM 0.5 mg PO DAILY 
5. Doxazosin 4 mg PO HS 
6. Glycopyrrolate 1 mg PO TID 
7. Lisinopril 20 mg PO DAILY 
8. Nuedexta (dextromethorphan-quinidine) ___ mg oral BID 
9. Warfarin 3 mg PO 2X/WEEK (MO,TH) 
10. Warfarin 6 mg PO 5X/WEEK (___) 
11. Docusate Sodium 100 mg PO BID 
RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice 
a day Disp #*30 Capsule Refills:*0
12. Enoxaparin Sodium 80 mg SC TWICE A DAY 
Start: Today - ___, First Dose: Next Routine Administration 
Time 
RX *enoxaparin 80 mg/0.8 mL 1 syringe subcutaneous twice a day 
Disp #*30 Syringe Refills:*0
13. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain 
RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours 
Disp #*20 Tablet Refills:*0
14. Senna 17.2 mg PO BID:PRN constipation 
RX *sennosides [senna] 8.6 mg 1 capsule by mouth twice a day 
Disp #*30 Capsule Refills:*0
15. Tamsulosin 0.4 mg PO DAILY 
RX *tamsulosin [Flomax] 0.4 mg 1 capsule(s) by mouth at bedtime 
Disp #*30 Capsule Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Left inguinal hernia 
 
Discharge Condition:
Level of Consciousness: Alert and interactive.
Activity Status: Non-ambulatory (baseline) 
 
Discharge Instructions:
Please call your doctor or nurse practitioner or return to the 
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or 
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your 
medications.
*You are getting dehydrated due to continued vomiting, diarrhea, 
or other reasons. Signs of dehydration include dry mouth, rapid 
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a 
bowel movement.
*You experience burning when you urinate, have blood in your 
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone 
within 24 hours. Call or return immediately if your pain is 
getting worse or changes location or moving to your chest or 
back.
*You have shaking chills, or fever greater than 101.5 degrees 
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern 
you.
 
Please resume all regular home medications, unless specifically 
advised not to take a particular medication. Also, please take 
any new medications as prescribed.
 
Please get plenty of rest, continue to ambulate several times 
per day, and drink adequate amounts of fluids. Avoid lifting 
weights greater than ___ lbs until you follow-up with your 
surgeon.

Avoid driving or operating heavy machinery while taking pain 
medications.

Incision Care:
*Please call your doctor or nurse practitioner if you have 
increased pain, swelling, redness, or drainage from the incision 
site.
*Avoid swimming and baths until your follow-up appointment.
*You may shower, and wash surgical incisions with a mild soap 
and warm water. Gently pat the area dry.
*If you have staples, they will be removed at your follow-up 
appointment.
*If you have steri-strips, they will fall off on their own. 
Please remove any remaining strips ___ days after surgery. 
 
 
Followup Instructions:
___
